SMMT
Summit Therapeutics Inc · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website ummittxinc.com
- Employees(FY) 76
- ISIN US86627T1088
Performance
+15.17%
1W
+13.16%
1M
+127.77%
3M
+303.2%
6M
+720.31%
YTD
+1073.15%
1Y
Profile
Summit Therapeutics Inc., a biopharmaceutical company, research and develops primarily oncology therapies in the United States, and the United Kingdom. The company's product pipeline includes SMT-738, a novel class of precision antibiotics for treatment which is in preclinical stage for the treatment of multidrug resistant infections, which primarily includes carbapenem-resistant Enterobacteriaceae infections. It has a collaboration and license agreement with Akeso, Inc. for research and develop Ivonescimab (AK112) and SMT112, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis. The company was founded in 2003 and is headquartered in Cambridge, Massachusetts.
Technical Analysis of SMMT 2024-11-08
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-08 07:00
2 Hot Biopharma Stocks to Buy and Hold for 5 Years(Motley Fool)
- 2024-11-04 18:56
Why Summit Therapeutics Stock Was a Winner Today(Motley Fool)
- 2024-11-04 14:14
- 2024-11-04 13:43
Summit Therapeutics Leads the Parade of Big Gainers(GuruFocus.com)
- 2024-11-03 06:41
3 Magnificent Stocks Under $100 to Buy in November(Motley Fool)
- 2024-10-31 08:42
- 2024-10-31 08:29
- 2024-10-31 07:01
- 2024-10-31 01:06
- 2024-10-30 07:39
Summit Therapeutics' Q3 Adjusted Loss Widens(MT Newswires)
- 2024-10-30 07:00
- 2024-10-29 19:00
- 2024-10-27 14:29
Is Summit Therapeutics a Millionaire Maker?(Motley Fool)
- 2024-10-27 09:14
- 2024-10-24 09:28
- 2024-10-24 05:13
- 2024-10-23 16:15
- 2024-10-23 09:41
- 2024-10-23 04:15
- 2024-10-22 07:00
- 2024-10-20 14:23
- 2024-10-15 06:30
- 2024-10-13 12:11
- 2024-10-12 09:15
- 2024-10-09 17:04
- 2024-10-07 05:29
- 2024-10-06 09:39
- 2024-10-05 11:12
Is Summit Therapeutics a Millionaire Maker?(Motley Fool)
- 2024-10-04 16:15
- 2024-10-04 09:41
Page 1 of 10
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.